You are here: Industry Insights > Acquires

News List

Marken Acquires Japanese Logistics Company prnasia
August 06, 2019
Marken announced today the acquisition of PCX International Co. Ltd based in Japan. PCX operates from their Tokyo headquarters to coordinate the delivery of over 3,000 clinical trial shipments per month.
ACG acquires Pharma Processing Equipment provider Xertecs GmbH expresspharma
August 05, 2019
ACG Engineering has acquired Germany-based pharma processing equipment company, Xertecs GmbH. The deal, which entails ACG acquiring 100 per cent shareholding, comes following a long and successful partnership between the two entities.
AbbVie acquires STING pathway-focused Mavupharma pharmaceutical-technology
July 17, 2019
Chicago-based AbbVie has announced its acquisition of Seattle-based oncology drug discovery company Mavupharma. The financial terms of the transaction were not disclosed.
Boehringer acquires AMAL Therapeutics for $366m pharmaceutical-technology
July 17, 2019
Boehringer Ingelheim has expanded its cancer immunology portfolio with the acquisition of Swiss biotechnology firm AMAL Therapeutics for up to €325m ($366m).
AbbVie Acquires Mavupharma americanpharmaceuticalreview
July 17, 2019
AbbVie has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel approaches to target the STING (STimulator of INterferon Genes) pathway for the treatment of cancer.
Novartis acquires ophthalmic drug from Takeda for $3.4bn pharmaceutical-technology
July 04, 2019
Novartis has acquired ophthalmic solution Xiidra (lifitegrast) 5% from Takeda Pharmaceutical for an upfront cash payment of $3.4bn.
Aptar acquires Nanopharm and Gateway Analytical expressbpd
June 14, 2019
Both acquisitions bring complementary, value-added and differentiated analytical, testing and development services for all stages of drug development and commercialisation
Thermo Fisher Scientific acquires HighChem biospectrumasia
June 10, 2019
HighChem software solutions are used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories
ASLAN Pharmaceuticals acquires rights to atopic dermatitis asset pharmaceutical-technology
June 05, 2019
ASLAN Pharmaceuticals has amended its licensing agreement with CSL to obtain complete worldwide rights to develop, manufacture and commercialise fully human monoclonal antibody (mAb) ASLAN004 across all indications.
Astellas Acquires Potenza Therapeutics pharmafocusasia
December 17, 2018
Astellas Pharma Inc today announced that it exercised, and closed on its exclusive option to acquire Potenza Therapeutics, Inc. ("Potenza") on December 13, 2018, U.S. Eastern Time.....

Previous page 1 2 3 Next page